<DOC>
	<DOCNO>NCT01078779</DOCNO>
	<brief_summary>A randomise control trial determine efficacy chloroquine prevention influenza</brief_summary>
	<brief_title>The Chloroquine Influenza Prevention Trial</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Chloroquine</mesh_term>
	<mesh_term>Chloroquine diphosphate</mesh_term>
	<criteria>Age 18 65 Have ability provide inform consent If woman childbearing potential , willing use contraception period trial Acute influenzalike illness screen History psoriasis , porphyria cutanea tarda , epilepsy , myasthenia gravis , myopathy cause , cardiac arrhythmia , serious hepatic renal disease Pregnancy breast feed Current use medication know serious hepatotoxic effect Current use medication know serious interaction CQ : amiodarone , anticonvulsant , ciclosporin , digoxin , mefloquine , moxifloxacin Current severe depression ( indicated current use antidepressant medication ) Known serious retinal disease Current recent ( within past 30 day ) participation clinical intervention trial . Known G6PD deficiency Vaccination influenza ( seasonal H1N1 strain ) within 3 month prior screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Prevention</keyword>
	<keyword>Chloroquine</keyword>
	<keyword>Randomised control trial</keyword>
	<keyword>Respiratory virus infection</keyword>
</DOC>